We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
101
Salesforce
CRM
$158B
$38.6M 0.25%
153,782
+36,293
+31% +$7.94M
UTHR icon
102
United Therapeutics
UTHR
$23.1B
$38.5M 0.25%
381,046
+62,710
+20% +$6.88M
PINS icon
103
Pinterest
PINS
$13.4B
$38.5M 0.25%
926,633
-280,981
-23% -$9.16M
ESI icon
104
Element Solutions
ESI
$9.23B
$38.4M 0.25%
3,657,751
+2,141,849
+141% +$23.5M
NVDA icon
105
NVIDIA
NVDA
$5.42T
$37.8M 0.24%
2,793,720
+2,338,320
+513% +$27.2M
TT icon
106
Trane Technologies
TT
$106B
$37.8M 0.24%
311,490
+63,830
+26% +$7.17M
PH icon
107
Parker-Hannifin
PH
$135B
$37.7M 0.24%
186,425
+68,217
+58% +$13.4M
XEC
108
DELISTED
CIMAREX ENERGY CO
XEC
$37.5M 0.24%
1,540,161
+245,518
+19% +$6.47M
RMD icon
109
ResMed
RMD
$30.7B
$37.2M 0.24%
+216,983
New +$40.1M
CSGP icon
110
CoStar Group
CSGP
$12.3B
$37.1M 0.24%
437,760
+136,630
+45% +$10.9M
CHX
111
DELISTED
ChampionX
CHX
$36.8M 0.24%
4,602,755
+601,150
+15% +$5.79M
SNOW icon
112
Snowflake
SNOW
$115B
$36.7M 0.24%
+146,253
New +$34.8M
SWK icon
113
Stanley Black & Decker
SWK
$15.7B
$36.3M 0.23%
223,947
+71,143
+47% +$11.1M
RY icon
114
Royal Bank of Canada
RY
$293B
$36M 0.23%
514,659
+342,985
+200% +$24.7M
CHE icon
115
Chemed
CHE
$7.22B
$35.8M 0.23%
74,485
-40,841
-35% -$20M
ALC icon
116
Alcon
ALC
$35B
$35.5M 0.23%
+623,663
New +$36.7M
ALNY icon
117
Alnylam Pharmaceuticals
ALNY
$29.3B
$35.3M 0.23%
242,660
-69,179
-22% -$9.83M
PCG icon
118
PG&E
PCG
$38.5B
$35.3M 0.23%
3,756,627
+1,376,731
+58% +$12.8M
MCK icon
119
McKesson
MCK
$101B
$34.9M 0.22%
234,290
-426,659
-65% -$64.8M
SHW icon
120
Sherwin-Williams
SHW
$89.8B
$34.7M 0.22%
149,496
-19,263
-11% -$4.21M
TRU icon
121
TransUnion
TRU
$15.3B
$34.2M 0.22%
+406,778
New +$35.1M
INTU icon
122
Intuit
INTU
$89B
$33.2M 0.21%
101,802
-363
-0.4% -$114K
UHS icon
123
Universal Health Services
UHS
$10.5B
$33.2M 0.21%
+310,120
New +$33.2M
MKTX icon
124
MarketAxess Holdings
MKTX
$5.72B
$33M 0.21%
68,532
+64,760
+1,717% +$32M
ASND icon
125
Ascendis Pharma A/S
ASND
$16.8B
$32.6M 0.21%
211,414
+60,923
+40% +$8.76M

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.